secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amneal Pharmaceuticals, Inc. (AMRX)
CIK:        0001723128
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001723128-25-000014
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Amneal promotes Jason Daly to EVP, Chief Legal Officer; base salary $575k
-------------------------------------------------------------------------

- Promoted from SVP to EVP, Chief Legal Officer & Corporate Secretary, effective March 1, 2025.
- Employment agreement includes initial term through March 31, 2027, with auto-renewal.
- Annual base salary of $575,000; bonus target 55% of base with performance multiplier 0-150%.
- Severance: 150% of salary, prorated bonus, 18-month benefits, and 12-month outplacement.
- Change-in-control protection: equity vesting acceleration and extended exercisability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1723128/000172312825000014/0001723128-25-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1723128/000172312825000014/amrx-20250301.htm
  HTML page:      https://secwatch.observer/filing/0001723128-25-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer